(Q44185150)

30 November 2017

title

Study of the drug release mechanism from tyrphostin AG-1295-loaded nanospheres by in situ and external sink methods (English)

1 reference

30 November 2017

Michael Chorny

1

1 reference

30 November 2017

Ilia Fishbein

series ordinal

2

1 reference

30 November 2017

Haim D Danenberg

series ordinal

3

1 reference

30 November 2017

Gershon Golomb

series ordinal

4

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 October 2002

1 reference

Journal of Controlled Release

30 November 2017

published in

1 reference

30 November 2017

volume

83

1 reference

30 November 2017

issue

3

1 reference

30 November 2017

page(s)

401-414

1 reference

PDGF-receptor tyrosine kinase blocker AG1295 selectively attenuates smooth muscle cell growth in vitro and reduces neointimal formation after balloon angioplasty in swine

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900210-9

7 January 2021

Local delivery of platelet-derived growth factor receptor-specific tyrphostin inhibits neointimal formation in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900210-9

7 January 2021

Lipophilic drug loaded nanospheres prepared by nanoprecipitation: effect of formulation variables on size, drug recovery and release kinetics

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900210-9

7 January 2021

Formulation and delivery mode affect disposition and activity of tyrphostin-loaded nanoparticles in the rat carotid model

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900210-9

7 January 2021

Preparation and characterisation of rose Bengal-loaded surface-modified albumin nanoparticles

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900210-9

7 January 2021

Drug delivery in poly(lactide-co-glycolide) nanoparticles surface modified with poloxamer 407 and poloxamine 908: in vitro characterisation and in vivo evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900210-9

7 January 2021

Synthesis and spectral properties of a hydrophobic fluorescent probe: 6-propionyl-2-(dimethylamino)naphthalene

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900210-9

7 January 2021

Nanoparticulate delivery system of a tyrphostin for the treatment of restenosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900210-9

7 January 2021

Anin vitrorelease kinetic examination and comparative evaluation between submicron emulsion and polylactic acid nanocapsules of clofibride

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900210-9

7 January 2021

Stability study of nanoparticles of poly(epsilon-caprolactone), poly(D,L-lactide) and poly(D,L-lactide-co-glycolide)

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900210-9

7 January 2021

Lidocaine loaded biodegradable nanospheres. II. Modelling of drug release

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900210-9

7 January 2021

Paclitaxel loaded poly(L-lactic acid) microspheres: properties of microspheres made with low molecular weight polymers

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900210-9

7 January 2021

Lidocaine-loaded biodegradable nanospheres. I. Optimization Of the drug incorporation into the polymer matrix.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900210-9

7 January 2021

10.1016/S0168-3659(02)00210-9

Identifiers

DOI

1 reference

30 November 2017

1 reference